Sexual Health

PT-141 (Bremelanotide)

Melanocortin receptor agonist that acts centrally on MC3R and MC4R in the hypothalamus. The only approved peptide treatment for hypoactive sexual desire disorder. Key compound in sexual neuroscience research.

Research specifications

Purity
≥98%
Unit
10mg
Sequence
NAFHFRWG
Length
8 amino acids
Molecular weight
1025.2
Availability
In stock